286 related articles for article (PubMed ID: 37907436)
1. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract][Full Text] [Related]
2. Increased healthcare costs by later stage cancer diagnosis.
McGarvey N; Gitlin M; Fadli E; Chung KC
BMC Health Serv Res; 2022 Sep; 22(1):1155. PubMed ID: 36096813
[TBL] [Abstract][Full Text] [Related]
3. Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.
Narang AK; Nicholas LH
JAMA Oncol; 2017 Jun; 3(6):757-765. PubMed ID: 27893028
[TBL] [Abstract][Full Text] [Related]
4. How Have Patient Out-of-pocket Costs for Common Outpatient Orthopaedic Foot and Ankle Surgical Procedures Changed Over Time? A Retrospective Study From 2010 to 2020.
Goldfarb SI; Xu AL; Gupta A; Mun F; Durand WM; Gonzalez TA; Aiyer AA
Clin Orthop Relat Res; 2024 Feb; 482(2):313-322. PubMed ID: 37498201
[TBL] [Abstract][Full Text] [Related]
5. Estimation of Patient Out-of-Pocket Cost for Radiation Therapy by Insurance Type and Treatment Modality.
Chen LW; Cao Y; D'Rummo K; Shen X
Pract Radiat Oncol; 2022; 12(6):e481-e485. PubMed ID: 35447387
[TBL] [Abstract][Full Text] [Related]
6. Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured.
Shih YT; Xu Y; Bradley C; Giordano SH; Yao J; Yabroff KR
J Natl Cancer Inst; 2022 Oct; 114(10):1392-1399. PubMed ID: 36099068
[TBL] [Abstract][Full Text] [Related]
7. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.
Leopold C; Wagner AK; Zhang F; Lu CY; Earle CC; Nekhlyudov L; Ross-Degnan D; Wharam JF
Breast Cancer Res Treat; 2018 Sep; 171(2):449-459. PubMed ID: 29855813
[TBL] [Abstract][Full Text] [Related]
8. Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.
Lu CY; Zhang F; Wagner AK; Nekhlyudov L; Earle CC; Callahan M; LeCates R; Xu X; Ross-Degnan D; Wharam JF
Breast Cancer Res Treat; 2018 Aug; 171(1):235-242. PubMed ID: 29754304
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacy, chemotherapy receipt, and medication-related out-of-pocket costs at end of life among commercially insured adults with advanced cancer.
McDermott CL; Curtis JR; Sun Q; Fedorenko C; Kreizenbeck K; Ramsey SD
J Oncol Pharm Pract; 2022 Jun; 28(4):836-841. PubMed ID: 33823685
[TBL] [Abstract][Full Text] [Related]
10. Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma.
Paro A; Hyer JM; Shaikh CF; Pawlik TM
Ann Surg Oncol; 2022 Sep; 29(9):5387-5397. PubMed ID: 35430665
[TBL] [Abstract][Full Text] [Related]
11. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer.
Davidoff AJ; Erten M; Shaffer T; Shoemaker JS; Zuckerman IH; Pandya N; Tai MH; Ke X; Stuart B
Cancer; 2013 Mar; 119(6):1257-65. PubMed ID: 23225522
[TBL] [Abstract][Full Text] [Related]
12. Patient Out-of-Pocket Cost Burden With Elective Orthopaedic Surgery.
Durand WM; Ortiz-Babilonia CD; Badin D; Wang KY; Jain A
J Am Acad Orthop Surg; 2022 Jul; 30(14):669-675. PubMed ID: 35797680
[TBL] [Abstract][Full Text] [Related]
13. Out-of-Pocket Spending for Asthma-Related Care Among Commercially Insured Patients, 2004-2016.
Sinaiko AD; Gaye M; Wu AC; Bambury E; Zhang F; Xu X; Wharam JF; Galbraith AA
J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4324-4331.e7. PubMed ID: 34481128
[TBL] [Abstract][Full Text] [Related]
14. Patient out-of-pocket spending in cranial neurosurgery: single-institution analysis of 6569 consecutive cases and literature review.
Yoon S; Mooney MA; Bohl MA; Sheehy JP; Nakaji P; Little AS; Lawton MT
Neurosurg Focus; 2018 May; 44(5):E6. PubMed ID: 29712524
[TBL] [Abstract][Full Text] [Related]
15. Out-of-pocket medical expenses compared across five years for patients with one of five common cancers in Australia.
Rodriguez-Acevedo AJ; Chan RJ; Olsen CM; Pandeya N; Whiteman DC; Gordon LG
BMC Cancer; 2021 Sep; 21(1):1055. PubMed ID: 34563142
[TBL] [Abstract][Full Text] [Related]
16. Out-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration in Standard-of-Care Early Stage Breast Cancer Treatment Across Medicaid and Medicare Plans.
Wu VS; Khlopin M; Jagsi R; McClelland S
Pract Radiat Oncol; 2024; 14(1):24-27. PubMed ID: 37748680
[TBL] [Abstract][Full Text] [Related]
17. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
[TBL] [Abstract][Full Text] [Related]
18. Increasing Out-of-Pocket Costs for Neurologic Care for Privately Insured Patients.
Hill CE; Reynolds EL; Burke JF; Banerjee M; Kerber KA; Magliocco B; Esper GJ; Skolarus LE; Callaghan BC
Neurology; 2021 Jan; 96(3):e322-e332. PubMed ID: 33361253
[TBL] [Abstract][Full Text] [Related]
19. The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients.
Koskinen JP; Färkkilä N; Sintonen H; Saarto T; Taari K; Roine RP
Acta Oncol; 2019 Jul; 58(7):1062-1068. PubMed ID: 30943813
[No Abstract] [Full Text] [Related]
20. The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia.
Spargo A; Yost C; Squires P; Raju A; Schroader B; Brown JD
J Manag Care Spec Pharm; 2021 May; 27(5):554-564. PubMed ID: 33908275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
